Filing Details
- Accession Number:
- 0001759655-22-000087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-07 18:25:58
- Reporting Period:
- 2022-07-05
- Accepted Time:
- 2022-07-07 18:25:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1759655 | Privia Health Group Inc. | PRVA | Services-Health Services (8000) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1859681 | Thomas Bartrum | Privia Health Group, Inc. 950 N. Glebe Rd., Suite 700 Arlington VA 22203 | Evp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value Per Share | Acquisiton | 2022-07-05 | 14,952 | $2.00 | 106,307 | No | 4 | M | Direct | |
Common Stock, $0.01 Par Value Per Share | Disposition | 2022-07-05 | 13,443 | $30.63 | 92,864 | No | 4 | S | Direct | |
Common Stock, $0.01 Par Value Per Share | Disposition | 2022-07-05 | 1,067 | $31.23 | 91,797 | No | 4 | S | Direct | |
Common Stock, $0.01 Par Value Per Share | Disposition | 2022-07-05 | 442 | $32.37 | 91,355 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Purchase) | Disposition | 2022-07-05 | 14,952 | $0.00 | 14,952 | $2.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
349,300 | 2033-08-27 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.97 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.00 to $31.54 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.02 to $33.02 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 300,150 of the stock options are fully vested and exercisable. 64,102 of the stock options will vest on October 29, 2022.